Literature DB >> 12422534

Antinociceptive action of extracts and fractions from Rubus imperialis (Rosaceae).

R Niero1, M Kanegusuku, M M Souza, R A Yunes, V Cechinel-Filho.   

Abstract

Rubus imperialis is a Brasilian medicinal plant which previously exhibited therapeutical perspectives. This work describes the antinociceptive action of methanolic extracts obtained from different parts of the plant (roots and branches) as well as hexane, chloroform and ethyl acetate fractions obtained from branches. Such extracts or fractions caused significative inhibition in the writhing test in mice at 10 mg/kg, given intraperitoneally. They were more active than two reference drugs, aspirin and paracetamol. The fractions also exhibited antinociceptive activity in the writhing test when administered orally at 200 mg/kg. When analyzed in the formalin test, the chloroform fraction was the most active, causing considerable inhibition against both neurogenic and inflammatory phases of pain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12422534

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  2 in total

1.  Evaluation of the gastroprotective activity of the extracts, fractions, and pure compounds obtained from aerial parts of Rubus imperialis in different experimental models.

Authors:  Priscila Elisabeth Berté; Jhonny da Silva Lopes; Nicole Garbin Comandulli; Daniele Wolff Rangel; Franco Delle Monache; Valdir Cechinel Filho; Rivaldo Niero; Sergio Faloni de Andrade
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-01-09       Impact factor: 3.000

2.  Rubus imperialis (Rosaceae) extract and pure compound niga-ichigoside F1: wound healing and anti-inflammatory effects.

Authors:  Talita Dacroce Tonin; Liliani Carolini Thiesen; Maria Luisa de Oliveira Nunes; Milena Fronza Broering; Marcos Paulo Donato; Marina Jagielski Goss; Marcel Petreanu; Rivaldo Niero; Isabel Daufenback Machado; José Roberto Santin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-08-15       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.